Key terms

About IONS

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest IONS news

Apr 09 7:06am ET Ionis Pharmaceuticals (IONS) Gets a Buy from Piper Sandler by TipRanks Apr 09 7:00am ET Analysts Are Bullish on Top Healthcare Stocks: Ionis Pharmaceuticals (IONS), Intuitive Surgical (ISRG) by TipRanks Apr 08 7:40pm ET Analysts Are Bullish on Top Healthcare Stocks: Ionis Pharmaceuticals (IONS), Intuitive Surgical (ISRG) by TipRanks Apr 08 7:15am ET Stifel Nicolaus Keeps Their Hold Rating on Ionis Pharmaceuticals (IONS) by TipRanks Apr 08 6:06am ET Ionis Pharmaceuticals Faces Sell Rating Amid Weak Clinical Results and Rising Competition by TipRanks Apr 08 5:50am ET Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Ionis Pharmaceuticals (IONS) and Medtronic (MDT) by TipRanks Apr 08 5:47am ET Buy Rating on Ionis Pharmaceuticals: Promising Clinical Data and Strategic Market Positioning for Olezarsen by TipRanks Apr 07 4:04pm ET Ionis Pharmaceuticals presents results from Phase 3 Balance study olezarsen by TipRanks Apr 03 5:55am ET Ionis Pharmaceuticals management to meet with Piper Sandler by TipRanks Apr 02 4:55am ET Ionis Pharmaceuticals management to meet with Piper Sandler by TipRanks Mar 28 10:40am ET Ionis Pharmaceuticals management to meet with Piper Sandler by TipRanks Mar 25 8:28am ET Ionis Pharmaceuticals to present data from Phase 3 on olezarsen by TipRanks Mar 18 7:50am ET Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Edwards Lifesciences (EW) and Aveanna Healthcare Holdings (AVAH) by TipRanks Mar 14 7:36am ET TD Cowen Sticks to Their Buy Rating for Ionis Pharmaceuticals (IONS) by TipRanks Mar 14 5:50am ET Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Ionis Pharmaceuticals (IONS) and Arcellx Inc (ACLX) by TipRanks Mar 13 7:10am ET Ionis announces results from Phase 2 study of ION224 by TipRanks Mar 06 8:17am ET Ionis Pharmaceuticals price target raised to $72 from $65 at Oppenheimer by TipRanks Mar 06 8:00am ET Analysts Offer Insights on Healthcare Companies: Nyxoah (NYXH), Ionis Pharmaceuticals (IONS) and Fusion Pharmaceuticals (FUSN) by TipRanks Mar 06 7:37am ET TD Cowen Keeps Their Buy Rating on Ionis Pharmaceuticals (IONS) by TipRanks Feb 29 9:22am ET Ionis Pharmaceuticals Announces Executive Advisory and Leadership Changes by TipRanks Feb 29 9:11am ET Ionis Pharma names Kyle Jenne new Chief Global Product Strategy Officer by TipRanks Feb 29 5:37am ET Ionis Pharmaceuticals: A Strong Buy on Robust Clinical Program Developments and Competitive Advantages by TipRanks Feb 26 8:05am ET Oppenheimer Sticks to Its Buy Rating for Ionis Pharmaceuticals (IONS) by TipRanks Feb 25 11:50pm ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Exact Sciences (EXAS), United Therapeutics (UTHR) and Ionis Pharmaceuticals (IONS) by TipRanks Feb 22 8:11am ET Ionis Pharmaceuticals price target raised to $63 from $62 at Piper Sandler by TipRanks Feb 22 8:00am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Nevro Corp (NVRO), Silver Spike Investment (SSIC) and Ionis Pharmaceuticals (IONS) by TipRanks Feb 22 7:38am ET Ionis Pharmaceuticals: A Strong Buy on ATTR Franchise Prospects and Financial Fortitude by TipRanks Feb 22 7:32am ET RBC Capital Remains a Buy on Ionis Pharmaceuticals (IONS) by TipRanks Feb 22 5:40am ET Analysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS), Ionis Pharmaceuticals (IONS) and Icon (ICLR) by TipRanks Feb 22 5:07am ET Barclays Remains a Hold on Ionis Pharmaceuticals (IONS) by TipRanks Feb 21 5:05pm ET Ionis Pharmaceuticals: A Buy Rating Based on Strong Q4 Earnings, Promising Pipeline, and Strategic Market Expansion by TipRanks

No recent news articles are available for IONS

No recent press releases are available for IONS

IONS Financials

1-year income & revenue

Key terms

IONS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

IONS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments